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Treatment with the connexin43 modulator, rotigaptide (ZP123) has been shown to protect against myocardial ischemia-reperfusion (I-R) 
injury in experimental studies. Our aim was to assess whether ZP123 exerts cardioprotection in isolated rabbit hearts subjected to I-R, 
and whether this effect interacts with the cardioprotective effects afforded by remote ischemic preconditioning (rIPC). rIPC was induced by 
four cycles of 5-minutes ischemia and reperfusion on the left hind limb. Hearts were explanted and mounted on a Langendorff apparatus 
and subjected to 30 minutes of global myocardial ischemia (MI) and 120 minutes of reperfusion. Rabbits were randomized into six groups 
(control, control + ZP123 before or after MI, rIPC, rIPC + ZP123 before or after MI). Infarct size was evaluated by tetrazolium staining. Left 
ventricular function was assessed using a balloon tipped catheter inserted in the left ventricle. ZP123 prior to MI or during reperfusion did 
not protect against I-R.. Co-administration of rIPC and ZP123 prior to MI showed a tendency to attenuate the infarct reducing effect of rIPC 
and abrogated the effect of rIPC when administered during reperfusion. No significant changes in hemodynamic recovery were observed. 
In conclusion, we found no cardioprotective effects by ZP123 in an in-vitro model. ZP123 showed a tendency to attenuate the effect of rIPC 
when administered prior to ischemia and abrogated the effect of rIPC when given during reperfusion.
 
